When Insurance Denies Injury Medications: Documentation and Appeal Strategies

James Wong — Founder & Pharmacist, LienScripts | July 26, 2024 | 8 min read

Insurance denial of injury-related medications is common, practically damaging, and documentarily useful — if you know how to respond. This guide covers the most common denial reasons, California's appeal process, and how denial history strengthens the case for pharmacy lien coverage.

The Denial Problem in PI Cases

Insurance denial of injury-related prescriptions is one of the most disruptive events in a personal injury case. Unlike a denied medical procedure that can be rescheduled while the appeal plays out, a medication denial often means a patient simply does not take their medication — creating treatment gaps, symptom exacerbation, and holes in the case record.

For PI attorneys, pharmacy denials deserve more attention than they typically receive at intake. The denial and appeal history is legally significant, clinically consequential, and practically useful for understanding how your client got where they are.

[!KEY] Enroll the client in a pharmacy lien the moment an insurance denial is identified — the appeal can proceed in parallel while the lien ensures medications continue without a clinical gap in the case record.

Common Reasons Injury Medications Are Denied

1. Accidental Injury Exclusions

Some health insurance policies — particularly older individual market policies and some employer plans — contain "accidental injury" exclusions that purport to exclude coverage for injuries caused by an accident where a third party may be liable. The logic is that the insurer does not want to cover costs when someone else is responsible.

California law significantly limits the enforceability of these exclusions in most contexts, but the practical problem is that a denial based on this clause means your client may not fill prescriptions while the appeal is pending. This is where the pharmacy lien becomes the immediate solution: enroll the client in a pharmacy lien so medications continue regardless of the insurance dispute.

2. Prior Authorization Delays and Denials

Many medications commonly prescribed in PI cases require prior authorization (PA) — a pre-approval process where the prescribing physician must document medical necessity to the insurer before the prescription will be covered. Common PA-requiring medications in PI cases include:

• Topical compounded analgesics
• Extended-release opioid formulations
• Pregabalin (Lyrica) — often requires prior failure of gabapentin
• Specialty agents including intrathecal pump medications

PA delays alone — even when the authorization is ultimately granted — mean days or weeks where the patient cannot afford to fill the prescription. For pain management medications, that gap has real clinical consequences.

3. Step Therapy ("Fail First") Requirements

Step therapy protocols require that a patient try a lower-cost medication before the insurer will approve the prescribed medication. This is extremely common with neuropathic pain agents:

• The prescriber orders pregabalin based on their clinical judgment
• The insurer requires the patient to first "fail" gabapentin (despite the prescriber's reasons for choosing pregabalin)
• The patient suffers suboptimal pain control during the step therapy period
• The prescriber must document the failure and resubmit for pregabalin authorization

California's Step Therapy Act (Health and Safety Code Section 1367.206) provides some protections, including the right to request an override of step therapy requirements when step therapy is clinically contraindicated. PI attorneys should know this exists and ensure their clients' treating physicians are using it.

4. Off-Label Use Denials

Many medications with established clinical use in PI cases are technically "off-label" — meaning they are prescribed for a purpose not listed in the FDA-approved labeling. Examples include:

• Gabapentin for neuropathic pain from injury (approved only for post-herpetic neuralgia and epilepsy)
• Duloxetine for chronic musculoskeletal pain — sometimes denied as not meeting criteria
• Low-dose naltrexone for CRPS — definitively off-label
• Amitriptyline for sleep and neuropathic pain — off-label for both uses

Off-label use is medically standard practice and routinely reimbursed by most insurers, but denials based on off-label use do occur. Appeal letters from the prescribing physician citing clinical guidelines and published evidence are often effective.

5. Non-Formulary Medications

If the prescribed medication is not on the insurer's formulary, it will typically require an exception process — essentially a prior authorization for a non-covered drug. Compound medications, some specialty agents, and newer branded medications frequently fall into this category.

The non-formulary denial is particularly relevant in PI cases because treating physicians may prescribe compounded topical analgesics (combining lidocaine, diclofenac, ketamine, and similar agents) that are virtually never on standard formularies.

[!KEY] Non-formulary and prior authorization denials are worth pursuing on appeal — a successful IMR or PA override both restores coverage and creates a written record of clinical necessity that strengthens the medical damages argument.

The California Appeal Process

When an insurer denies a prescription coverage request, California law provides a structured appeal pathway through the Department of Managed Health Care (DMHC) for fully insured plans (note: ERISA self-insured employer plans have their own internal review requirements under federal law).

Level 1: Internal Appeal

The first step is an internal appeal with the insurer. Requirements:

• Submit a written appeal within the plan's stated deadline (typically 180 days from the denial)
• Include the prescriber's letter of medical necessity — a clinical letter explaining why this specific medication is necessary for this specific patient
• Include relevant clinical records supporting the diagnosis and treatment rationale
• Reference California law where applicable (step therapy protections, off-label coverage obligations)

The insurer must resolve standard internal appeals within 30 days for prospective denials and 72 hours for urgent cases.

Level 2: Independent Medical Review (IMR)

If the internal appeal is denied — or if the issue is medical necessity — California law gives enrollees of fully insured plans the right to request an Independent Medical Review (IMR) through the DMHC. Key points:

• The IMR is conducted by an independent organization contracted with DMHC
• The decision is binding on the insurer
• The IMR must be completed within 30 days (3 days for expedited/urgent cases)
• There is no cost to the enrollee to request IMR
• IMR is only available for fully insured plans — ERISA self-insured plans have their own external review rights under federal law

IMR has a meaningful success rate for medically necessary medications that were denied on clinical grounds. The IMR reviewer is a clinician, not a claims adjuster, which tends to produce more clinical-evidence-based outcomes.

Expedited Appeal for Urgent Situations

When a patient's condition is urgent — defined as a situation where standard appeal timelines would seriously jeopardize the patient's health — California law requires the insurer to complete an expedited internal appeal within 72 hours and an expedited IMR within 3 days. PI attorneys with clients in acute pain situations should always request expedited review.

[!TIP] Request complete EOBs from your client's health insurer — denied claims for injury-related medications are exhibits that demonstrate both the barriers your client faced and a written record of the insurer's own assessment of causation.

Documentation Strategy: The Denial Record Strengthens the PI Case

Here is the perspective shift that matters for PI attorneys: an insurance denial record is not just an obstacle — it is evidence.

Denial letters establish the insurer's assessment of the injury. When an insurer denies coverage on grounds of a pre-existing condition exclusion and the treating physician appeals citing the injury as causative, that dispute creates a written record of causation.

Step therapy documentation demonstrates the severity of the medical need. When a physician appeals step therapy requirements because the patient's condition is too severe for the lower-tier medication, that letter is clinical documentation of injury severity.

EOBs showing denials are exhibits. Request complete Explanation of Benefits (EOB) documents from your client's health insurer. EOBs showing denied claims for injury-related medications — alongside the corresponding appeal records — become part of the medical damages file.

In cases where the client ultimately could not fill prescriptions during the denial process, the resulting treatment gap itself becomes a damages element: the plaintiff was injured by the defendant's negligence and then further harmed by being unable to access prescribed medications due to insurance barriers.

[!KEY] An unresolved insurance denial that caused a medication gap is itself a compensable damages element — document it with the denial letter, the prescribing physician's appeal, and a medical narrative describing the clinical consequences of the interrupted treatment.

Pharmacy Lien as the Practical Solution

The appeal process can take weeks to months. For an injured patient who needs pain medication today, the correct practical response is not to wait for the appeal — it is to enroll in a pharmacy lien so that medications continue uninterrupted while the appeal proceeds.

A pharmacy lien removes the insurance gatekeeping problem entirely for injury-related medications. The patient gets the medications their physician prescribed, the case record remains continuous, and the lien is resolved at settlement.

For clients who arrive at your office with an insurance denial already in place, the immediate next step is pharmacy lien enrollment — followed by pursuing the appeal for the historical period where medications may have been denied and unpaid.

Learn how LienScripts supports California PI attorneys navigating insurance denial situations.

Related Resources

• Prior Authorization Workarounds in PI Cases
• Non-Formulary Medications for PI Attorneys
• Insurance Denial and Medication Access
• Early Pharmacy Lien Enrollment and Case Strength